Effects of sulfonylurea derivatives on ischemia-induced loss of function in the isolated rat heart

European Journal of Pharmacology

Volumn 419, Issue 1, 2001, Pages 85-92

  Legtenberg, Roger J ^a   Houston, Ralph J F ^a,b   Oeseburg, Berend ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiovascular; Diabetes type 2; Heart; KATP channel; Ventricular

Indexed keywords

GLIBENCLAMIDE; GLIMEPIRIDE; SULFONYLUREA DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; AORTA FLOW; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DRUG EFFECT; ERYTHROCYTE; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART PERFUSION; ISOLATED HEART; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CORONARY CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; HEART; MALE; MYOCARDIAL STUNNING; RATS; RATS, WISTAR; SULFONYLUREA COMPOUNDS;

EID: 0035805271     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00974-8     Document Type: Article

References (33)

1. + channel opener cromakalim on recovery of cardiac function from cardioplegic arrest in isolated perfused rat hearts. Asia Pac. J. Pharmacol. 8:1993;173-179.
2. Ashcroft F.M. Mechanisms of the glycaemic effects of sulphonylureas. Horm. Metab. Res. 28:1996;456-463.
3. Auchampach J.A., Maruyama M., Cavero I., Gross G.J. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation. 86:1992;311-319.
4. Aversano T., Ouyang P., Silverman H. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ. Res. 69:1991;618-622.
5. Bijlstra P.J., Lutterman J.A., Russel F.G.M., Thien T., Smits P. Interaction of sulfonylurea derivatives with vascular ATP-sensitive potassium channels in humans. Diabetologia. 39:1996;1083-1090.
6. Billman G.E., Avedano C.E., Halliwill J.R., Burroughs J.M. The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetised dogs. J. Cardiovasc. Pharmacol. 21:1993;197-204.
7. ATP channels. Diabetes. 45:1996;1439-1445.
8. Coetzee W.A. ATP-sensitive potassium channels and myocardial ischaemia: why do they open? Cardiovasc. Drugs Ther. 6:1992;201-208.
9. + channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 69:1991;571-581.
10. Daut J., Rudolph W.M., von Beckerath N., Meherke G., Gunther K., Meinen L.G. Hypoxic vasodilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science. 247:1990;1341-1344.
11. 31P NMR studies. J. Mol. Cell. Cardiol. 29:1997;1665-1673.
12. El-Reyani N.E., Bozdogan O., Baczko I., Lepran I., Papp J.G. Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats. Eur. J. Pharmacol. 365:1999;187-192.
13. Geisen K., Vegh A., Krause E., Papp J.G. Cardiovascular effects of conventional sulfonylureas and glimepiride. Horm. Metab. Res. 28:1996;496-507.
14. Gerich J.E. Oral hypoglycemic agents. N. Engl. J. Med. 321:1989;1231-1245.
15. Groop L.C. Sulfonylureas in NIDDM. Diabetes Care. 15:1992;737-754.
16. Gross G.J., Auchampach J.A. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70:1992;223-233.
17. Imamura Y., Tomoike H., Narishige T., Takahashi T., Kasuya H., Takeshita A. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am. J. Physiol. 263:1992;H399-H404.
18. + channels. Neuron. 16:1996;1011-1017.
19. + channel. J. Biol. Chem. 271:1995;24321-24324.
20. Klepzig H., Kober G., Matter C., Luus H., Schneider H., Boekeker K.H., Kiowski W., Amann F.W., Gruber D., Harris S., Burger W. Sulfonylureas and ischaemic preconditioning. A double blind, placebo-controlled evaluation of glimepiride and glibenclamide. Eur. Heart J. 20:1999;439-446.
21. Langendorff O. Untersuchungen am überlebenden Säugethierherzen. Pflügers Arch. 61:1895;291-332.
22. Lederer W.J., Nichols C.G. Nucleotide modulation of the activity of rat heart ATP-sensitive K channels in isolated membrane patches. J. Physiol. (London). 66:1989;913-931.
23. Mitani A., Kinoshita K., Fukamachi K., Sakamoto M., Kurisu K., Tsuruhara Y., Fukumura F., Nakashima A., Tokunaga K. Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts. Am. J. Physiol. 261:1991;H1864-H1871.
24. Neely J.R., Liebermeister H., Battersby E.J., Morgan H.E. Effect of pressure development on oxygen consumption by isolated rat heart. Am. J. Physiol. 212:1967;804-814.
25. Nichols C.G., Ripoll C., Lederer W.J. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Circ. Res. 68:1991;280-287.
26. + channels in cardiac muscle. Nature. 305:1989;147-148.
27. Olders J., Boumans T., Evers J., Turek Z. An experimental set-up for the blood perfused working isolated rat heart. Adv. Exp. Med. Biol. 277:1990;151-160.
28. Olders J., Turek Z., Evers J., Hoofd L., Oeseburg B., Kreuzer F. Comparison of Tyrode and blood perfused working isolated rat hearts. Adv. Exp. Med. Biol. 277:1990;403-414.
29. Podesser B.K., Hallström S., Schima H., Huber L., Weisser J., Kröner A., Fürst W., Wolner E. The erythrocyte-perfused "working heart" model: hemodynamic and metabolic performance in comparison to crystalloid perfused hearts. J. Pharmacol. Toxicol. 41:1999;9-15.
30. Russel F.G.M., van Uum S., Tan Y., Smits P. Solid-phase extraction of 18β-glycyrrhetinic acid from plasma and subsequent analysis by high-performance liquid chromatography. J. Chromatogr., B. 710:1998;223-226.
31. Samaha F.F., Heineman F.W., Ince C., Fleming J., Balaban R.S. ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am. J. Physiol. 262:1992;C1220-C1227.
32. Tosaki A., Hellegouarch A. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. JACC. 23:1994;487-496.
33. + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am. J. Physiol. 274:1998;C25-C37.